Cargando…
High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis
Background: The only available tuberculosis (TB) vaccine, Bacillus Calmette-Guérin (BCG), has variable efficacy. New vaccines are therefore urgently needed. Why BCG fails is incompletely understood, and the tools used for early assessment of new vaccine candidates do not account for BCG variability....
Autores principales: | Zelmer, Andrea, Stockdale, Lisa, Prabowo, Satria A., Cia, Felipe, Spink, Natasha, Gibb, Matthew, Eddaoudi, Ayad, Fletcher, Helen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039926/ https://www.ncbi.nlm.nih.gov/pubmed/30026926 http://dx.doi.org/10.12688/f1000research.14239.2 |
Ejemplares similares
-
Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
por: Prabowo, Satria A., et al.
Publicado: (2019) -
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
por: Painter, Hannah, et al.
Publicado: (2020) -
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
por: Prabowo, Satria A., et al.
Publicado: (2019) -
Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization
por: Kewcharoenwong, Chidchamai, et al.
Publicado: (2018) -
Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer
por: Adamkiewicz, Mateusz, et al.
Publicado: (2021)